227 related articles for article (PubMed ID: 12213057)
1. Molecular modeling of the interactions of glutamate carboxypeptidase II with its potent NAAG-based inhibitors.
Rong SB; Zhang J; Neale JH; Wroblewski JT; Wang S; Kozikowski AP
J Med Chem; 2002 Sep; 45(19):4140-52. PubMed ID: 12213057
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: efficacy as analgesic agents.
Kozikowski AP; Zhang J; Nan F; Petukhov PA; Grajkowska E; Wroblewski JT; Yamamoto T; Bzdega T; Wroblewska B; Neale JH
J Med Chem; 2004 Mar; 47(7):1729-38. PubMed ID: 15027864
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the glutamate carboxypeptidase II gene in mice reveals a second enzyme activity that hydrolyzes N-acetylaspartylglutamate.
Bacich DJ; Ramadan E; O'Keefe DS; Bukhari N; Wegorzewska I; Ojeifo O; Olszewski R; Wrenn CC; Bzdega T; Wroblewska B; Heston WD; Neale JH
J Neurochem; 2002 Oct; 83(1):20-9. PubMed ID: 12358725
[TBL] [Abstract][Full Text] [Related]
4. Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate (NAAG).
Hicks C; Gregg RA; Nayak SU; Cannella LA; Schena GJ; Tallarida CS; Reitz AB; Smith GR; Rawls SM
Psychopharmacology (Berl); 2017 Jun; 234(11):1671-1681. PubMed ID: 28251297
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of glutamate carboxypeptidase II (GCPII) inhibitors.
Ferraris DV; Shukla K; Tsukamoto T
Curr Med Chem; 2012; 19(9):1282-94. PubMed ID: 22304717
[TBL] [Abstract][Full Text] [Related]
6. Kinetics and inhibition of glutamate carboxypeptidase II using a microplate assay.
Rojas C; Frazier ST; Flanary J; Slusher BS
Anal Biochem; 2002 Nov; 310(1):50-4. PubMed ID: 12413472
[TBL] [Abstract][Full Text] [Related]
7. S1 pocket of glutamate carboxypeptidase II: a new binding site for amyloid-β degradation.
Lee SK; Kim H; Cheong YH; Kim MJ; Jo SA; Youn HS; Park SI
Biochem Biophys Res Commun; 2013 Sep; 438(4):765-71. PubMed ID: 23891752
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation.
Thomas AG; Olkowski JL; Slusher BS
Eur J Pharmacol; 2001 Aug; 426(1-2):35-8. PubMed ID: 11525768
[TBL] [Abstract][Full Text] [Related]
9. Regulation of glutamate carboxypeptidase II hydrolysis of N-acetylaspartylglutamate (NAAG) in crayfish nervous tissue is mediated by glial glutamate and acetylcholine receptors.
Urazaev AK; Grossfeld RM; Lieberman EM
J Neurochem; 2005 May; 93(3):605-10. PubMed ID: 15836619
[TBL] [Abstract][Full Text] [Related]
10. Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity.
Nan F; Bzdega T; Pshenichkin S; Wroblewski JT; Wroblewska B; Neale JH; Kozikowski AP
J Med Chem; 2000 Mar; 43(5):772-4. PubMed ID: 10715144
[No Abstract] [Full Text] [Related]
11. Binding of the glutamate carboxypeptidase II (NAALADase) inhibitor 2-PMPA to rat brain membranes.
Tiffany CW; Cai NS; Rojas C; Slusher BS
Eur J Pharmacol; 2001 Sep; 427(2):91-6. PubMed ID: 11557259
[TBL] [Abstract][Full Text] [Related]
12. Design of NAALADase inhibitors: a novel neuroprotective strategy.
Jackson PF; Slusher BS
Curr Med Chem; 2001 Jul; 8(8):949-57. PubMed ID: 11375762
[TBL] [Abstract][Full Text] [Related]
13. Still NAAG'ing After All These Years: The Continuing Pursuit of GCPII Inhibitors.
Vornov JJ; Hollinger KR; Jackson PF; Wozniak KM; Farah MH; Majer P; Rais R; Slusher BS
Adv Pharmacol; 2016; 76():215-55. PubMed ID: 27288079
[TBL] [Abstract][Full Text] [Related]
14. N-acetylaspartylglutamate (NAAG) is the probable mediator of axon-to-glia signaling in the crayfish medial giant nerve fiber.
Gafurov B; Urazaev AK; Grossfeld RM; Lieberman EM
Neuroscience; 2001; 106(1):227-35. PubMed ID: 11564432
[TBL] [Abstract][Full Text] [Related]
15. Human glutamate carboxypeptidase II inhibition: structures of GCPII in complex with two potent inhibitors, quisqualate and 2-PMPA.
Mesters JR; Henning K; Hilgenfeld R
Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):508-13. PubMed ID: 17372356
[TBL] [Abstract][Full Text] [Related]
16. Blockade of NAALADase: a novel neuroprotective strategy based on limiting glutamate and elevating NAAG.
Vornov JJ; Wozniak K; Lu M; Jackson P; Tsukamoto T; Wang E; Slusher B
Ann N Y Acad Sci; 1999; 890():400-5. PubMed ID: 10668445
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-aspartyl-glutamate and inhibition of glutamate carboxypeptidases protects against soman-induced neuropathology.
Guo H; Liu J; Van Shura K; Chen H; Flora MN; Myers TM; McDonough JH; McCabe JT
Neurotoxicology; 2015 May; 48():180-91. PubMed ID: 25825357
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of N-acetylaspartylglutamate in a neonatal rat model of hypoxia-ischemia.
Cai Z; Lin S; Rhodes PG
Eur J Pharmacol; 2002 Feb; 437(3):139-45. PubMed ID: 11890901
[TBL] [Abstract][Full Text] [Related]
19. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
[TBL] [Abstract][Full Text] [Related]
20. In silico approaches to identify the potential inhibitors of glutamate carboxypeptidase II (GCPII) for neuroprotection.
Naushad SM; Janaki Ramaiah M; Stanley BA; Prasanna Lakshmi S; Vishnu Priya J; Hussain T; Alrokayan SA; Kutala VK
J Theor Biol; 2016 Oct; 406():137-42. PubMed ID: 27430729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
